Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

AcT Trial: Protocol for a Pragmatic Registry-Linked Randomized Clinical Trial.

Stroke (Hoboken, N.J.)·2026

Same author

Endovascular Acute Stroke Intervention-Tandem Occlusion (EASI-TOC) study: protocol and rationale.

European stroke journal·2026

Same author

Tubeless Insulin Pump Combined with a Cloud-Based Data Management Platform: Real-World Evidence from 14,765 French People with Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2025

Same author

Portal vein-enriched metabolites as intermediate regulators of the gut microbiome in insulin resistance.

Cell metabolism·2025

Same author

Intravenous tenecteplase is associated with a higher incidence of thrombus movement before endovascular treatment for acute ischemic stroke: a secondary analysis of the AcT randomized controlled trial.

Journal of neurointerventional surgery·2025

Same author

Design of a peripherally biased NPSR1 antagonist for neuropeptide S induced inflammation.

Bioorganic & medicinal chemistry letters·2025

Search research articles

Related Experiment Video

Updated: May 21, 2026

Generating Human Pancreatic Tissue Slices to Study Endocrine and Exocrine Pancreas Physiology

Generating Human Pancreatic Tissue Slices to Study Endocrine and Exocrine Pancreas Physiology

Published on: March 15, 2024

[Technological advances in diabetology].

François Moreau¹, Lucile Ratheau, Anne-Hélène Spizzo

¹Hôpitaux Universitaires de Strasbourg.

Soins; La Revue De Reference Infirmiere

|June 27, 2012

Summary

Diabetes mellitus management has advanced significantly, from ancient practices to modern insulin therapy and blood sugar monitoring. Pancreas and islet cell transplantation offer promising therapeutic options for patients.

More Related Videos

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Experiment Videos

Last Updated: May 21, 2026

Generating Human Pancreatic Tissue Slices to Study Endocrine and Exocrine Pancreas Physiology

Generating Human Pancreatic Tissue Slices to Study Endocrine and Exocrine Pancreas Physiology

Published on: March 15, 2024

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

Endocrinology
Transplantation immunology
Metabolic diseases

Context:

The historical understanding and management of diabetes mellitus have undergone substantial evolution.
Current diabetes care includes simplified insulin administration, urine testing, and blood glucose monitoring.
Significant advancements in transplantation have emerged over recent decades.

Purpose:

To provide an overview of the historical progression and modern advancements in diabetes mellitus management.
To highlight the therapeutic potential of pancreas and islet of Langerhans transplantation.

Summary:

Diabetes mellitus understanding spans from antiquity to contemporary times, with major improvements in patient monitoring and insulin delivery.
Pancreas transplantation has been an option for over 30 years, while islet of Langerhans transplantation has been available for 15 years.
These transplantation methods represent significant progress in offering hope and treatment alternatives for diabetes.

Impact:

Improved quality of life for individuals with diabetes through advanced therapies.
Expanded therapeutic avenues for diabetes treatment beyond conventional methods.
Potential for long-term glycemic control and reduced diabetes complications through transplantation.